Gilead Sciences Inc (NASDAQ: GILD)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 04/22/2022
Closing price: 62.25
|Support price level:||N/A|
|Resistance price level:||$63.59|
|Relative strength index (14-day RSI)||63.3|
- The price of this low-beta stock is expected to increase by 0.34% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- GILD is below its 200-day moving average - additional caution warranted in long positions.
- Price broke below prior support level - a short-term bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 6.1% in the next week.
- 13.7% in the next month.
- 38.7% in the next year.